MYRIAD GENETICS INC — Director's Dealing 2022

Jun 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2022-06-09

Reporting Person: Hart Jayne B. (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-09	Common Stock	A	1036	$14.841	Acquired	182511	Direct

Footnotes

F1: These shares were acquired under the Myriad Genetics, Inc. 2012 Amended and Restated Employee Stock Purchase Plan, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).